Search results
Kansas’ congressional delegation dives into VA, Native boarding schools, Pfizer lawsuit
Kansas Reflector via Yahoo News· 37 minutes agoMoran shares frustrations with VA, Davids lauds bill on Native boarding schools and Marshall...
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 7 days agoPfizer (PFE) closed at $27.41 in the latest trading session, marking a +1.59% move from the prior...
UK Government Snubs GSK in Favor of Pfizer’s Rival RSV Shot
Bloomberg· 1 day agoHave a confidential tip for our reporters? GSK Plc has lost out to Pfizer Inc. on a contract to...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Alnylam Stock Pops on Surprising Results From a Key Heart Disease Drug
Barrons.com· 1 day agoAlnylam said that patients with a rare heart condition called ATTR amyloidosis...The reduction was...
Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
InvestorPlace· 1 day agoHeart disease drugmaker Alnylam (NASDAQ:ALNY) stock rose sharply on the success of a Phase 3 study...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoManagement is looking for around $25 billion in additional annual revenue by 2030 from its business development deals. These acquisitions haven't...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 4 days agoIts revenues have jumped from $28.3 billion in 2021 to $34.1 billion in 2023. Conclusion While other...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 7 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
Alnylam's drug cuts risk of death, heart issues in key study, shares jump
Reuters via Yahoo News· 1 day ago(Reuters) -Alnylam Pharmaceuticals said its drug vutrisiran reduced deaths and cardiovascular events by a third in a study involving patients with a rare heart disease, sending the ...